TNF-α-induced E3 ligase, TRIM15 inhibits TNF-α-regulated NF-κB pathway by promoting turnover of K63 linked ubiquitination of TAK1

Cell Signal. 2022 Mar:91:110210. doi: 10.1016/j.cellsig.2021.110210. Epub 2021 Dec 3.

Abstract

Ubiquitin E3-ligases are recruited at different steps of TNF-α-induced NF-κB activation; however, their role in temporal regulation of the pathway remains elusive. The study systematically identified TRIMs as potential feedback regulators of the TNF-α-induced NF-κB pathway. We further observed that TRIM15 is "late" response TNF-α-induced gene and inhibits the TNF-α-induced NF-κB pathway in several human cell lines. TRIM15 promotes turnover of K63-linked ubiquitin chains in a PRY/SPRY domain-dependent manner. TRIM15 interacts with TAK1 and inhibits its K63-linked ubiquitination, thus NF-κB activity. Further, TRIM15 interacts with TRIM8 and inhibits cytosolic translocation to antagonize TRIM8 modualted NF-κB. TRIM8 and TRIM15 also show functionally inverse correlation in psoriasis condition. In conclusion, TRIM15 is TNF-α-induced late response gene and inhibits TNF-α induced NF-κB pathway hence a feedback modulator to keep the proinflammatory NF-κB pathway under control.

Keywords: Functional antagonism; NF-κB; TNF-α; TRIM15; TRIM8; Ubiquitination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carrier Proteins / metabolism
  • Humans
  • NF-kappa B* / metabolism
  • Nerve Tissue Proteins / metabolism
  • Signal Transduction
  • Tumor Necrosis Factor-alpha / metabolism
  • Ubiquitin-Protein Ligases* / metabolism
  • Ubiquitination

Substances

  • Carrier Proteins
  • NF-kappa B
  • Nerve Tissue Proteins
  • TRIM8 protein, human
  • Tumor Necrosis Factor-alpha
  • Ubiquitin-Protein Ligases